Investigational drug · Phase 2
RN0361
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Hypertriglyceridemia, Familial Chylomicronemia Syndrome.
Phase 2Last checked: Nov 19, 2026Latest source record: Dec 30, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "RN0361"
First trial start
2024
Sep 30, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "RN0361", any sponsor or status.
Conditions studied
As listed on its trial records.
- Hypertriglyceridemia
- Familial Chylomicronemia Syndrome
Approved drugs for the same conditions: High triglycerides · Cardiovascular and metabolic · Rare and genetic disease
Largest trials
Live from ClinicalTrials.gov: studies naming "RN0361" as an intervention, largest first.
- Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic SubjectsPivotal-lookingCompleted
Ikaria Bioscience Pty LtdIndustry
NCT06471543 · 108 participants · Start Sep 30, 2024 · Primary completion Jun 3, 2026
Drug: RN0361 · For: Hypertriglyceridemia; Familial Chylomicronemia Syndrome
Sites: Tamarac, Florida; Versailles, Kentucky; Dilworth, Minnesota · 10 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Hypertriglyceridemia
- SHR-1918Phase 37 trials
Beijing Suncadia Pharmaceuticals Co., Ltd · Homozygous Familial Hypercholesterolemia, Hyperlipidemia, Hypercholesterolemia
- DR10624Phase 35 trials
Zhejiang Doer Biologics Co., Ltd. · Severe Hypertriglyceridemia, Hypertriglyceridemia, Severe Hypertriglyceridemia (sHTG)
- MAR001Phase 23 trials
Marea Therapeutics · Hypertriglyceridemia
- RBD5044Phase 22 trials
Ribocure Pharmaceuticals AB · Dyslipidemias, Hypertriglyceridemia
- ION775Phase 21 trial
Ionis Pharmaceuticals · Hypertriglyceridemia, Severe Hypertriglyceridemia
- JMT202Phase 21 trial
Shanghai JMT-Bio Inc. · Hypertriglyceridemia
- MN-001Phase 21 trial
MediciNova · Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.